Libera Bio
Addressing “undruggable intracellular targets” in oncology
Libera Bio is active in the biopharma, life science, oncology, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2020.
Libera Bio is positioned in biopharma, life science, oncology, pharmaceutical, a segment that rewards a clear, focused offering.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $1.3M.
| Sector | Biopharma, Life Science, Oncology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | ES |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $1,300,000 |
Website: www.liberabio.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account